Why drug used to treat critically ill COVID-19 patients may only benefit males

A new study shows how dexamethasone, the main treatment for severe COVID-19 lung infections, alters how immune cells work, which may help male patients, but has little to no benefit for females.


Click here for original story, Why drug used to treat critically ill COVID-19 patients may only benefit males


Source: ScienceDaily